Supreme LMA and Endotracheal Intubation Use in Caesarean Section
Launched by WEI YU YAO · May 16, 2013
Trial Information
Current as of May 04, 2025
Completed
Keywords
ClinConnect Summary
We propose a randomised controlled trial to study the first attempt insertion success rate of supreme LMA versus endotracheal intubation in general anaesthesia for elective Caesarean section.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Age 18 to 50 years old
- • ASA 1 or 2
- • Fasted at least 6 hours
- • Weight 40 to 75kg
- • Normal airway assessment
- • Singleton term pregnancy (\>36weeks)
- • Elective Caesarean section
- Exclusion Criteria:
- • In labour
- • Body mass index \>35
- • Difficult airway (Mallampati 4 or abnormal airway assessment)
- • Gastrooesophageal reflux disease
About Wei Yu Yao
Wei Yu Yao is a pioneering clinical trial sponsor dedicated to advancing medical research and innovation. With a focus on developing cutting-edge therapies, the organization collaborates with leading research institutions and healthcare professionals to conduct rigorous clinical trials. Committed to patient safety and ethical standards, Wei Yu Yao emphasizes transparency and scientific integrity in its operations. By fostering partnerships and leveraging expertise, the sponsor aims to bring transformative treatments to market, ultimately improving patient outcomes and enhancing quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Shi Y Li, MD
Study Director
Quanzhou Women's and Children's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials